Mittal Rea, Pinero Colon Yael, Church Ephraim W, Yallapragada Anil
Neurology, Penn State College of Medicine, Hershey, USA.
Neurology, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
Cureus. 2022 Feb 25;14(2):e22605. doi: 10.7759/cureus.22605. eCollection 2022 Feb.
We present the case of an ischemic stroke associated with partially occlusive acute calcified cerebral emboli large vessel occlusion (CCE LVO). No revascularization strategy guidelines have been established for this unique acute ischemic stroke population, although many studies have reported impaired and inconsistent responses to both thrombolysis and thrombectomy. The patient in this case report, unfortunately, experienced a failed attempt at complete thrombolysis, resulting in a poor clinical outcome. Endovascular thrombectomy was not performed because of incomplete obstruction and risk of injury. Follow-up imaging revealed an acute ischemic stroke at the large middle cerebral artery and a new intraparenchymal hemorrhage with complete absence of the previously identified calcified embolus. This case and current literature demonstrate that more data are needed to determine the best revascularization approach for patients with CCE LVO stroke. With tissue plasminogen activator marginally effective in these patients, thrombectomy should be considered in highly unstable, clinically symptomatic patients even only with partial vessel occlusion.
我们报告了一例与部分闭塞性急性钙化性脑栓塞大血管闭塞(CCE LVO)相关的缺血性卒中病例。尽管许多研究报告称,溶栓和取栓治疗对此独特的急性缺血性卒中人群的反应受损且不一致,但尚未针对这一群体制定血管再通策略指南。不幸的是,本病例报告中的患者溶栓未成功,导致临床预后不佳。由于阻塞不完全和受伤风险,未进行血管内取栓。随访影像显示大脑中动脉主干出现急性缺血性卒中,并有新的脑实质内出血,之前发现的钙化栓子完全消失。该病例及现有文献表明,需要更多数据来确定CCE LVO卒中患者的最佳血管再通方法。鉴于组织型纤溶酶原激活剂在这些患者中效果甚微,对于高度不稳定、有临床症状的患者,即使只是部分血管闭塞,也应考虑进行取栓治疗。